Supplementary Online Content

Similar documents
Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.

Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

eappendix A. Opioids and Nonsteroidal Anti-Inflammatory Drugs

Mina Tadrous, Diana Martins, Zhan Yao, Kimberly Fernandes, Samantha Singh, Nikita Arora, David Juurlink, Muhammad Mamdani and Tara Gomes

Supplementary Online Content

Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:

Supplementary Online Content

Psychosocial Problems In Reproductive Health Of Elders

Supplementary Online Content

AHA Clinical Science Special Report: November 10, 2015

Supplementary Online Content

Supplementary Online Content

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.

TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 8 Episodes

Supplementary Online Content

Supplementary Online Content

Appendix 1: Supplementary tables [posted as supplied by author]

Supplementary Online Content

Zhao Y Y et al. Ann Intern Med 2012;156:

Supplementary Online Content

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Supplementary Online Content

Supplementary Online Content

HealtheCNY Indicator List by Data Source

Jacqueline C. Barrientos, Nicole Meyer, Xue Song, Kanti R. Rai ASH Annual Meeting Abstracts 2015:3301

Supplementary Online Content

Pharmaceutical Misuse and its Challenges: Opioid Use in Ontario. Ontario Harm Reduction Conference Tara Gomes Tuesday January 31, 2012

APPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10

Maryland s Behavioral Health Crisis. The Hospital Perspective

Pharmacy Prep. Qualifying Pharmacy Review

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

4. Which survey program does your facility use to get your program designated by the state?

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham

Health Quality Ontario

Variation in the Risk of Suicide Attempts and Completed Suicides by Antidepressant Agent in Adults

Appendix Identification of Study Cohorts

Supplementary Online Content

Supplementary Online Content

Executive Report was an active year for the Regional Center for Poison Control and Prevention Serving Massachusetts and Rhode Island.

Supplementary Online Content

Supplementary Online Content

Public Mental Health. Benedetto Saraceno University Nova of Lisbon University of Geneva Chairman Global Initiative on Psychiatry, The Netherlands

HDSA welcomes you to Caregiver s Corner. Funded by an educational grant from

Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database

chapter 10 INJURIES Deaths from injuries are declining, but they are still a major cause of mortality

Barbara G. Wells, PharmD, FASHP, FCCP, BCPP Dean and Professor School of Pharmacy, The University of Mississippi Oxford, Mississippi

Benzodiazepine as an Adjuvant in Management of Depression

10 INDEX Acknowledgements, i

3. Correct coding practice is to select the code with the greater number of characters available.

Appendix. TABLE E-1 Distribution by OTA/AO Fracture Classification 13 : Nonsignificant Group Difference Self-Reported Marijuana Use

Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study

STOPP START Toolkit Supporting Medication Review in the Older Person

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Medicare and Medicaid Payments

Changing patterns of sedative use over time in older adults in Ontario

Policy Brief June 2014

Supplementary figures and tables. Figure A: Study schematic

Malaysian Healthy Ageing Society

Supplementary Online Content

Health Care in Appalachia. Foundations of Modern Health Care, Lecture 12 Anya K. Cope, DO

Supplementary Online Content

Comprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma

Supplementary Online Content

ACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...

ASSIGNMENT OF BENEFITS

Child and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014

Supplementary Online Content

Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database

Looking for Balance: Antipsychotic medication use in Ontario long-term care homes. Technical Appendix

Data Sources, Methods and Limitations

Driving and Pain. Guidance for Faculty of Pain Medicine Members

Supplementary Online Content

Supplementary Online Content

Physical and Medical Impairments in Elderly Drivers

Referral Form PERSONAL DETAILS. Reason for Referral: Please indicate clearly your reason for referral: CONTACT PERSONS Next of Kin 1: Name:

Antidepressant use and risk of adverse outcomes in people aged years: cohort study using a primary care database

ICD-10-CM Coding and Documentation for Long Term Care

Evaluating Exam Review Book and Guide

Pharmacotherapy Handbook

New York Medicaid Beneficiaries with Mental Health and Substance Abuse Conditions

Supplementary Online Content

Supplementary Online Content

Working Paper Distribution and types of multiple chronic conditions in Korea. Young-Ho Jung, Sukja Ko

Delirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine

Supplementary Online Content

MEDICAL HISTORY. Previous Nephrologist. Medication taken Insulin Oral Both. Who manages your diabetes? Blindness Yes No Hearing Problems Yes No

In each hospital-year, we calculated a 30-day unplanned. readmission rate among patients who survived at least 30 days

Cognitive enhancers for the treatment of Alzheimer s disease

Supplementary Digital Content Section A Procedural codes to define study population

Thompson Centre Intensive Treatment Program Physician Referral Form

The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability

NATIONAL SURVEILLANCE OF OSTEOARTHRITIS AND RHEUMTOID ARTHRITIS IN CANADA

Supplementary Online Content

UI α (n=150) Mean (SD) or N (%)

Identifying Adult Mental Disorders with Existing Data Sources

Depression in the Medically Ill

Transcription:

Supplementary Online Content Gomes T, Redelmeier DA, Juurlink DN, et al. Opiod dose and risk of road trauma in Canada: a populationbased study. JAMA Intern Med. Published online January 14, 2013. doi:10.1001/2013.jamainternmed.733. etable 1. Place of occurrence codes used to identify road trauma in emergency departments. etable 2. Components of disease risk score used to match cases to controls etable 3. Characteristics of all cases and potential controls efigure. Association between opioid dose and road trauma among all cases and potential controls This supplementary material has been provided by the authors to give readers additional information about their work.

etable 1. Place of occurrence codes used to identify road trauma in emergency departments Place of Occurrence, ICD 10 Code Suffix Patient Position Vehicle Involved V01 V09 All Pedestrian Various vehicles V10 V19 All Miscellaneous Pedal bicycle V20 V29 0, 2, 3, 4, 6, 8, 9 Driver Motorcycle V20 V29 1, 5 Passenger Motorcycle V30 V39 0, 3, 4, 5, 8, 9 Driver All terrain vehicle V30 V39 1, 6 Passenger All terrain vehicle V30 V39 2, 7 Pedestrian All terrain vehicle V40 V49 0, 3, 4, 5, 8, 9 Driver Automobile V40 V49 1, 6 Passenger Automobile V40 V49 2, 7 Pedestrian Automobile V50 V59 0, 3, 4, 5, 8, 9 Driver Small truck V50 V59 1, 6 Passenger Small truck V50 V59 2, 7 Pedestrian Small truck V60 V69 0, 3, 4, 5, 8, 9 Driver Big truck V60 V69 1, 6 Passenger Big truck V60 V69 2, 7 Pedestrian Big truck V70 V79 0, 5 Driver Bus V70 V79 1, 3, 4, 6, 8, 9 Passenger Bus V70 V79 2, 7 Pedestrian Bus V80 All Miscellaneous Animal rider V81 V82 All Passenger Train or Streetcar V83 V86 0, 3, 4, 5, 9 Driver Industrial V83 V86 1, 6 Passenger Industrial V83 V86 2, 7 Pedestrian Industrial V87 V89 All Miscellaneous Uncertain Abbreviation: ICD 10, International Statistical Classification of Diseases, 10th Revision.

etable 2. Components of disease risk score used to match cases to controls Variable ICD-9 Diagnosis Code ICD-10 Diagnosis Code OHIP Diagnosis Code Demographic Characteristics (measured on index date) Age Sex Estimated residential income Neighborhood income quintile based on location of residence on index quintile date Residence in a long-term care Based on LTC flag on most recent ODB prescription in past 1 year facility Rurality of principal residence Rural community defined as community with 10,000 residents Medical disorders (measured by presence in 3 years before index date) Acute myocardial infarction 410 I21 410, 413 Alcohol abuse V113, 291, 303.0, 303.9, F10, G31.2, G62.1, G72.1, 291, 303 305.0, 357.5, 425.5, 535.3, 571.0, 571.1, 571.3, 790.3, 980.0 I42.6, I70.0, K29.2, K70.1, K70.4, K70.9, K86.0, R78.0, T51.0, X65, Y15, Y91, Z50.1, Z71.4, Z86.40 Atherosclerotic disease 414.0, 440 I251, I70 440 Chronic lung disease 490.0, 491, 492.0, 494.0, J40-J44, J47 491, 492, 496.0 Dementia 290, 331.0, 331.1, 331.2, 797 F00, F01, F02.0, F02.1, F03, F05.1, G30, G31.0, G31.1, R54 Diabetes mellitus index date Dyslipidemia 272.0-272.6, 272.9 E78.0-E78.6, E78.9, E88.1, H02.6 Gastrointestinal tract hemorrhage 494, 496 290, 331, 797 Defined as diagnosis date in Ontario Diabetes Database that precedes the 531.0, 531.2, 531.4, 531.6, 532.0, 532.2, 532.4, 532.6, 533.0, 533.2, 533.4, 533.6, 534.0, 534.2, 534.4, 534.6, 578.0, 578.1, 578.9 K25.0, K25.2, K25.4, K25.6, K26.0, K26.2, K26.4, K26.6, K27.0, K27.2, K27.4, K27.6, K28.0, K28.2, K28.4, K28.6, K92.0, K92.1, K92.2 Glaucoma 365 H40, H42 365 Gout 274 M10 274 Heart failure 428 I50 428 Hypothyroidism 244.1, 244.3, 244.8, E01.8, E02, E03.2, E03.3, 244 244.9 E03.5, E03.8, E03.9, E89.0 Injury other than poisoning 8XX, 90-95 S* T00-T35 Osteoarthritis 715 M15.0-M15.2, M15.4, M16-715 M19, M89.41-M89.43, M89.45-M89.46, M89.48 Other coronary heart disease 411.0, 412.0, 413.0, I20, I24.0, I24.8, I24.9, I25.1, 412 414.0, 414.8, 414.9 I25.2, I25.5, I25.6, I25.8, I25.9 Parkinson s disease 332.0-332.1 G20, G21.1, G21.2, G21.3, 332 G21.8, G21.9, G22 272

Pneumonia 480-486 J10-J18 486 Poisoning or drug toxicity 96-98 T36-T65 977 Rheumatoid arthritis 714.0-714.4, 714.8 M05, M06, M08.0, M08.2-714 M08.4, M08.8, M08.9, M09, M12.0 Seizure disorder 780.3, 345 R56.0, R56.8, G40, G41 345 Sepsis 038 A40, A41 Stroke 430-438 I60, I61, I62, 432-436 I63, I64, G45 Urinary incontinence 788.3 N39.3, N39.4, R32 Psychiatric disorders (measured by presence in 3 years before index date) Affective disorder 296 F30, F31, F32.2, F32.3, F32.8, F33, F34.8, F34.9, F38, F39 Anxiety or sleep disorders 300 F32.0, F34.1, F40-F42, F44, Psychoses, agitation, and related disorders 292, 293.0, 293.8, 294, 295, 297.1, 297.3, 297.8, 297.9, 299 All other mental disorders 301, 302.2-302.9, 304.0-304.6, 304.9, 305.1-305.7, 305.9, 306.4, 306.5, 306.8, 306.9, 307, 308.3, 308.9, 309.0, 309.2, 309.8, 310.1, 310.2, 310.8, 310.9, 311.0, 312.0-312.3, 312.8, 312.9, 313.0, 313.2, 313.3, 313.8, 313.9, 314.0, 314.2, 314.8, 314.9, 315, 316.0 Other variables Suicide attempt in 3 years before index date Number of visits to a physician in the past 1 year before index date Care by a psychiatrist in 1 year before index date Days in hospital during 1 year before index date 95.0-95.9 X60-X84 F45.0-F45.2, F48, F68.0, F99 F02.2-F02.4, F02.8, F04, F05.0, F05.8, F05.9, F06.0- F06.6, F06.8, F06.9, F09, F11.0, F11.3-F11.9, F12.0, F12.3-F12.9, F13.0, F13.3-F13.9, F14.0, F14.3-F14.9, F15.0, F15.3-F15.9, F16.0, F16.3-F16.9, F17.0, F17.3-F17.9, F18.0, F18.3-F18.9, F19.0, F19.3-F19.9, F20-F22, F23.2, F24, F25, F53.1, F84 F06.7, F07, F11.1, F11.2, F12.1, F12.2 F13.1, F13.2, F14.1, F14.2 F15.1, F15.2, F16.1, F16.2 F17.1, F17.2, F18.1, F18.2 F19.1, F19.2, F32.9, F43, F45.3, F45.4, F45.8, F45.9, F50, F51, F52, F53.0, F54-F59, F60-F66, F68.1, F68.8, F69, F80-F83, F88-F95, F98, G44.2 Count only one OHIP claim per person per physician per day. Main specialty in IPDB = psychiatry 296 300 295, 297 301, 302, 304, 305, 306-316 Defined as sum of total length of stay of all hospitalizations discharged in prior year

Abbreviations: ICD 9, International Classification of Diseases, Ninth Revision; ICD 10, International Statistical Classification of Diseases, 10th Revision; IPDB, Institute for Clinical Evaluative Sciences Physician Database; LTC, longterm care; ODB, Ontario Drug Benefit; OHIP, Ontario Health Insurance Plan.

etable 3. Characteristics of all CASES AND POTENTIAL CONTROLS Controls N = 43 736 Cases N = 6006 Standard. Difference Age (mean, SD), y 48.89 ± 9.72 45.51 ± 9.95 0.35 Sex (male) 20 054 (45.9%) 3151 (52.5%) 0.13 Income quintile Missing 261 (0.6%) 39 (0.6%) <0.01 1 18 694 (42.7%) 2587 (43.1%) <0.01 2 10 235 (23.4%) 1440 (24.0%) 0.01 3 6479 (14.8%) 838 (14.0%) 0.02 4 4852 (11.1%) 644 (10.7%) 0.01 5 3215 (7.4%) 458 (7.6%) 0.01 Urban residence 36 770 (84.1%) 5031 (83.8%) <0.01 ODB plan coverage Social assistance 7007 (16.0%) 1370 (22.8%) 0.18 Disability support 29 945 (68.5%) 4059 (67.6%) 0.02 Other 6784 (15.5%) 577 (9.6%) 0.17 Charlson Comorbidity Index No hospitalization 28 591 (65.4%) 3621 (60.3%) 0.11 0 7931 (18.1%) 1459 (24.3%) 0.16 1 3004 (6.9%) 437 (7.3%) 0.02 2 or more 4210 (9.6%) 489 (8.1%) 0.05 Duration of opioid use 7.23 ± 3.82 7.07 ± 3.68 0.04 Comorbidity measures in past 1 year ED visit for alcohol abuse 757 (1.7%) 355 (5.9%) 0.28 ED visit for road trauma 404 (0.9%) 990 (16.5%) 0.99 ED visit for drug toxicity 809 (1.8%) 262 (4.4%) 0.17 Total number of ED visits (Mean, SD*) 1.59 ± 3.72 4.68 ± 8.03 0.69 Total number of physician visits (Median, IQR**) 18 (10-31) 22 (13-38) 0.20 Total number of visits to a family physician (median, IQR) 10 (5-17) 13 (7-21) 0.26 Visit to a psychiatrist 6779 (15.5%) 1209 (20.1%) 0.13 Medication ue in past 180 days Number of drugs dispensed (mean, SD) 12.17 ± 6.87 12.53 ± 7.27 0.05 SSRI 15 672 (35.8%) 2210 (36.8%) 0.02 Other antidepressant 15 102 (34.5%) 2011 (33.5%) 0.02 Antipsychotic 6423 (14.7%) 1052 (17.5%) 0.08 Benzodiazepines 21 333 (48.8%) 3158 (52.6%) 0.08 Other CNS depressants 2901 (6.6%) 381 (6.3%) 0.01 Comorbidity measures in past 3 years Hospitalization for poisoning or drug toxicity 6073 (13.9%) 1229 (20.5%) 0.19

Alcohol abuse 3576 (8.2%) 806 (13.4%) 0.19 Affective disorder 3946 (9.0%) 683 (11.4%) 0.08 Anxiety or sleep disorders 26 834 (61.4%) 4234 (70.5%) 0.19 Psychoses 2482 (5.7%) 505 (8.4%) 0.12 Other mental disorders 20 901 (47.8%) 3495 (58.2%) 0.21 Injury 1559 (3.6%) 425 (7.1%) 0.18 Osteoarthritis 15 956 (36.5%) 2184 (36.4%) <0.01 Rheumatoid arthritis 2958 (6.8%) 362 (6.0%) 0.03 Abbreviations: CNS, central nervous system; ED, emergency department; IQR: Interquartile Range; ODB, Ontario Drug Benefit; SSRI, selective serotonin reuptake inhibitor.

efigure. Association between opioid dose and road trauma among all cases and potential controls, adjusted for age, sex, public drug plan, Charlson score, past hospitalization for alcoholism (3 years), past emergency department (ED) visit for alcoholism (1 year), number of ED visits in past 1 year, ED visit for road trauma (past 1 year), number of physician visits (past 1 year), number of visits to a family physician (past 1 year), visit to a psychiatrist (past 1 year), hospitalization for drug poisoning (past 1 year), ED visit for drug poisoning (past 1 year), duration of opioid use, medication use in past 180 days (selective serotonin reuptake inhibitors, other antidepressants, antipsychotics, benzodiazepines and other depressants of the central nervous system, separately), number of drugs dispensed in past 180 days, history of sleep disorders, psychoses, other mental disorders, or injury in the past 3 years.